Josh Gottheimer
Josh Gottheimer (D-NJ) sold $1K-$15K of $ABT (Abbott Laboratories Common Stock (ABT)) on Mar 6, 2025, part of 48 transactions in this filing (15 buys, 33 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 42
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
5 flagsRep. Gottheimer sold $1,001 - $15,000 in $DHI on 2025-03-19 — 8 days before the 'Revitalizing Downtowns and Main Streets Act' (HR2410) was introduced, a bill proposing an investment tax credit for converting non-residential buildings.
Rep. Gottheimer sold $1,001 - $15,000 in $HD on 2025-03-19 — 8 days before the 'Revitalizing Downtowns and Main Streets Act' (HR2410) was introduced, a bill proposing an investment tax credit for converting non-residential buildings.
Rep. Gottheimer sold $1,001 - $15,000 in NOW on 2025-03-19 — 8 days before the 'Strengthening Agency Management and Oversight of Software Assets Act' (HR2417) was introduced, a bill mandating software assessments and management plans.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $APP | Applovin Corporation - Class A Common Stock (APP) | $1K-$15K | $272.00 | — | — | Mar 13, 2025 |
| BUY | $ASML | ASML Holding N.V. - New York Registry Shares (ASML) | $1K-$15K | $703.37 | — | — | Mar 12, 2025 |
| BUY | $BKNG | Booking Holdings Inc. - Common Stock (BKNG) | $1K-$15K | $196.70 | — | — | Mar 5, 2025 |
| BUY | $BKNG | Booking Holdings Inc. - Common Stock (BKNG) | $1K-$15K | $196.70 | — | — | Mar 4, 2025 |
| BUY | $DASH | DoorDash, Inc. - Common Stock (DASH) | $1K-$15K | $178.29 | $176.78 | -0.8% | Mar 13, 2025 |
| BUY | $FI | Fiserv, Inc. Common Stock (FI) | $1K-$15K | $214.62 | — | — | Mar 10, 2025 |
| BUY | $GILD | Gilead Sciences, Inc. - Common Stock (GILD) | $1K-$15K | $117.41 | $130.40 | +11.1% | Mar 7, 2025 |
| BUY | $ICE | Intercontinental Exchange Inc. Common Stock (ICE) | $1K-$15K | $134.40 | — | — | Mar 18, 2024 |
| BUY | $IBM | International Business Machines Corporation Common Stock (IBM) | $1K-$15K | $256.90 | $231.98 | -9.7% | Mar 10, 2025 |
| BUY | $META | Meta Platforms, Inc. - Class A Common Stock (META) | $1K-$15K | $656.47 | $675.03 | +2.8% | Mar 5, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Strengthening Agency Management and Oversight of Software Assets Act
HR2417 is an early-stage authorization bill requiring federal agencies to inventory and manage software assets. No new money is appropriated. The bill is stuck in committee with no floor schedule. Real market data shows Oracle ($ORCL) down 6.34% in 7 days to $162.30, ServiceNow ($NOW) down 4.08% in 7 days and 17.27% in 30 days to $86.49 — these moves are unrelated to this dormant procedural bill.
United States Leadership in Immersive Technology Act of 2025
HR2321 (United States Leadership in Immersive Technology Act of 2025) is an early-stage bill referred to committee in March 2025. It establishes a purely advisory panel with no funding authorizations or appropriations, creating zero near-term financial impact on any public company.
Expanded Student Saver’s Tax Credit Act
HR2852 (Expanded Student Saver's Tax Credit Act) is an early-stage bill that would allow full-time students to claim the Saver's Credit and later the Saver's Match. The bill has zero appropriated funding — it modifies eligibility rules only. With just 2 cosponsors and referral to the Ways and Means Committee, it faces a long legislative path. The market impact on financial sector stocks is negligible. No executive action from April 20, 2026 is relevant to this bill.
American Innovation and R&D Competitiveness Act of 2025
HR1990, the American Innovation and R&D Competitiveness Act, would restore immediate expensing for R&D costs, reversing the 2022 tax code change that required 5/15-year amortization. This is an early-stage bill referred to Ways and Means with 81 cosponsors, but if enacted, it would provide a direct 21% tax-rate cash flow benefit annually to every R&D-intensive US company. The largest absolute beneficiaries are mega-cap tech and pharma firms with $10B+ annual R&D budgets.
Choice in Automobile Retail Sales Act of 2025
HR 2165, introduced in March 2025, removes EPA authority to mandate EV technology or limit ICE vehicle availability. The bill remains in early legislative stages with 11 cosponsors and is referred to committee, but it signals a clear regulatory agenda protecting traditional automotive and oil/gas value chains. Real market data shows Ford at $11.85 (down 4.28% in 7 days), GM at $77.67 (down 0.49%), and Stellantis at $7.21 (down 10.55%), while energy tickers XOM ($154.39, +3.68%), CVX ($192.41, +3.89%), KMI ($32.61, +2.74%), and ET ($19.95, +4.56%) have rallied in the same period.
Providing Veterans Essential Medications Act
HR1970 (Providing Veterans Essential Medications Act) is in early legislative stages, having been referred to the House Veterans' Affairs subcommittee. The bill mandates VA reimbursement for high-cost medications dispensed to veterans in State nursing homes, but authorizes no specific funding and remains months from passage. Real market data shows CVS up 16% in 30 days while CAH is down 10%, reflecting broader distribution-sector dynamics rather than this early-stage bill.
Protecting Life and Integrity in Research Act of 2025
HR2075 is an early-stage House bill that would ban federal funding for research using human fetal tissue from induced abortions. It is stuck in committee with no floor action since introduction in March 2025. The market data shows a broad 30-day decline across biomedical stocks, but $TMO and $DHR have moved -1.19% and +0.72% respectively in the past 7 days — not signaling acute legislative risk. The bill has zero direct appropriations and remains a low-probability risk factor for life sciences tool suppliers.
Strengthening Supply Chains Through Truck Driver Incentives Act of 2025
HR2391 is a stalled, early-stage bill with zero market impact. Trucking stocks JBHT, ODFL, and KNX have rallied 7–16% over the past 30 days, but this move is unrelated to this bill and reflects broader transportation demand or macro factors. The bill has been stuck in committee since March 2025 with only 3 cosponsors.
Protecting Employees and Retirees in Business Bankruptcies Act of 2025
S. 1381 (Protecting Employees and Retirees in Business Bankruptcies Act of 2025) is an early-stage Senate bill that would structurally increase bankruptcy costs for labor-intensive companies. For UAL and GM, the bill elevates employee and retiree claims in Chapter 11, raising bankruptcy risk premiums. At impact score 3, near-term market effects are minimal, but the structural risk is real if the bill advances through the Judiciary Committee.
Revitalizing Downtowns and Main Streets Act
HR2410, the Revitalizing Downtowns and Main Streets Act, proposes a 20% tax credit for converting non-residential buildings into affordable housing. Introduced March 27, 2025, it remains in early legislative stages in the House Ways and Means Committee with no near-term market impact. Monitored homebuilders ($LEN, $DHI, $PHM, $KBH, $NVR) show neutral direct exposure; real beneficiaries would be commercial real estate owners and adaptive reuse developers not represented in this ticker set.
Other Filings by Josh Gottheimer
Free — no credit card
Get the next Gottheimer trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.